Nachrichten zur Incyte Corp. Aktie

Incyte: Auf Wachstumskurs mit neuen Medikamenten gegen Krebs und Autoimmunerkrankungen

Die Zahl diagnostizierter Autoimmun- und Krebserkrankungen ist in den vergangenen Jahren deutlich gestiegen, vor allem dank verbesserten Diagnosemöglichkeiten. In Deutschland…

Insider Trading Activity: Becton Dickinson, BNY, Incyte, Duolingo, and Jabil CEOs and Executives Sell Stocks

Insider Trading Activity: Becton Dickinson, BNY, Incyte, Duolingo, and Jabil CEOs and Executives Sell Stocks…

Insider Trading Activity: Becton Dickinson, BNY, Incyte, Duolingo, and Jabil CEOs and Executives Sell Stocks

Insider Trading Activity: Becton Dickinson, BNY, Incyte, Duolingo, and Jabil CEOs and Executives Sell Stocks…

Becton Dickinson, BNY, Incyte, Duolingo, Jabil: Major Stock Sales Unveiled!

Insiders have been trading these 5 stocks: (($BDX)), (($BK)), (($INCY)), (($DUOL)) and (($JBL)). Here is a breakdown of their recent…

Incyte Gains 9.2% in Three Months: Buy, Hold or Sell the Stock?

INCY stock climbs 9.2% in three months as FDA approvals and a new diagnostic deal fuel pipeline momentum.…

FDA Extends INCYs Application for Opzelura Label Expansion

FDA extends review of Incytes ruxolitinib cream for children with atopic dermatitis, delaying decision to September 2025.…

Incyte Gets FDA Nod for the Expanded Use of Monjuvi in Lymphoma

The FDA approves INCYs Monjuvi in combination with rituximab and lenalidomide for relapsed/refractory follicular lymphoma, its second approved indication.…

QGEN Stock Rises in After Market Following Partnership With Incyte

QIAGEN teams up with Incyte to develop NGS-based companion diagnostics for blood cancers.…

dpa-AFX ProFeed